Smart Start New Horizons · Shaping the Global Growth Pole Together —— The 2025 Frost & Sullivan New Investment Conference Concludes Successfully

On August 28th, the 19th Frost & Sullivan Global Growth, Innovation and Leadership Summit 2025 and the 4th New Investment Conference (hereinafter referred to as '2025 Frost & Sullivan New Investment Conference' or 'Conference'), hosted by Frost & Sullivan and co-organized by LeadLeo, successfully concluded at the Shanghai Jing'an Shangri-La Hotel. The conference brought together over 200 heavyweight guests from home and abroad, with more than 100 presentations/roundtables, and the expected professional audience size at the event will exceed 4,000 people.

The theme of this conference is "Intelligent Start, New Journey - Co-shaping Global Growth Poles." Supported by the China Listed Companies Association, the China Advertising Association, and China Quality Supervision, it brings together the wisdom and strength of the global industry, academia, and investment community to jointly explore new growth points, new markets, and new tracks for China's economy in the new era. The conference lasts for two days and consists of an opening ceremony, eight sub-forums, and multiple themed activities, focusing on hot topics such as AI and the digital economy, new investments in life sciences, new consumption trends, ESG and new quality productivity, high-quality development of listed companies, intelligent manufacturing going global, and the globalization development of Chinese enterprises.

At the same time, the conference will be broadcast online synchronously through platforms such as Xinhua News Agency client, Frost & Sullivan video account, LeadLeo video account, LeadLeoplus video account, Weibo Health, Weibo Medicine, Dongcai, WandData, Tianfeng, Tonghuashun, Roadshow China, Xueqiu, Value Online, Trading Treasure, Futu, and Brand Think Tank Research Institute.

The inaugural conference gathered a distinguished group of talents, shining with brilliance. With the participation of hundreds of guests, it successfully concluded. Guests from institutions, enterprises, and universities presented a lively and unique intellectual feast to both online and offline audiences. On August 28th, the AI Evolution Theory - Physical World Intelligent System Construction Forum, High-Quality Development Forum for Listed Companies, New Investment Summit in Life Sciences (Parallel Sessions) —— Medical Special Session, New Investment Summit in Life Sciences (Parallel Sessions) —— Instrumental Special Session were successfully held.

AI Evolutionary Theory - Physical World Intelligence System Construction Forum

In the transformative wave of artificial intelligence moving from virtual to physical worlds, on August 28, 2025, Frost & Sullivan's new investment conference specially launched the AI Evolution - Physical World Intelligent Systems Construction Forum, co-hosted by Frost & Sullivan and LeadLeo. The forum brought together experts and scholars in the global AI industry, industry leaders, innovative enterprises, investment institutions, and professional service providers to discuss the new momentum injected into traditional disciplines by "AI +", analyze the top 50 most transformative technologies of 2025, gain insights into the IPO and refinancing trends of the Hong Kong AI industry, and share cutting-edge hot topics such as vertical large models, embodied intelligent service robots, synthetic data, and intelligent cockpits.

Key speakers attending the event included Yang Xiaocheng, Partner and Managing Director of Frost & Sullivan Greater China; Sae-Jun Park, Head of Frost & Sullivan Korea; Wan Yong, Chairman of SULLIVAN TELE-TREND CLOUD TECHNOLOGY and Chief Executive Officer of TradeGo; Liu Mingrui, Partner of Ernst & Young Strategy and Transaction Consulting; Dr. Liu Jun, Chairman of Relyon Technology; Ravi Krishnaswamy, Managing Director of Frost & Sullivan Asia-Pacific; Fang Chao, Chief Advisor of HAICHUANG AI, Professor at Huazhong University of Science and Technology, Chief Strategic Scientist at Beijing Yizhuang Artificial Intelligence Research Institute and Hubei Optics Valley Laboratory; Zhang Di, Brand and Business Head of Yipji; Yu Youping, President of Zhongguancun Kejin; Wan Bin, COO of Qingleang; Yang Zijiang, Founder of Shenzhen Xinke Technology Information Co., Ltd.; Wang Fei, Executive Director of SenseTime Jieying; Nie Kaixuan, Founder and CEO of Shanghai Songying Technology; Yang Laitu, CEO of Siwei ZhiLian; Zheng Yajing, CFO of HuiZhi International, etc.

At the event, the 'White Paper on AI Empowering All Industries', 'Best Application Practices in China's GenAI Industry 2025', 'Best Practice Application List of Chinese Al Agents (Intelligent Entities) 2025', 'Insights into the Development of Synthetic Data Solutions in China 2025', 'Insights into the Development of World Models in China 2025', and 'Insights Report on the Development of Specialized, Refined, Innovative Enterprises in China 2025' were released. The Frost & Sullivan quadrant chart report plan for the entire year of 2025 in the AI field was also presented.

New Investment Summit Forum on Life Sciences

With the continuous progress of global technology and the growing demand for healthcare, the field of life sciences has embraced unprecedented development opportunities. From gene editing, precision medicine to biopharmaceuticals, as well as the research and application of high-end medical devices, innovative achievements in the field of life sciences are emerging in an endless stream, injecting new vitality into the global healthcare industry. On August 28th, the New Life Sciences Investment Summit Forum —— Medical Devices Session gathered industry leaders, biopharmaceutical companies, medical device companies, investment institutions, and professional service providers under the theme of 'Strengthening Foundations and Stabilizing the Waves'. The forum focused on cutting-edge trends, innovative technologies, and globalization development strategies in the field of life sciences, aiming to promote industrial development and global cooperation.

New Investment Summit Forum in Life Sciences - New Investment Summit Forum in Life Sciences (Parallel Session) —— Medicine Special Session

Key speakers including Wang Chenhui, Managing Partner and President of Frost & Sullivan Greater China; Professor Wang Yu, President of the China Liver Disease Foundation; Rhenu Bhuller, Strategic Advisor to Life Sciences and Digital Health at Frost & Sullivan; He Jianqi, Head of R&D Development (Asia) at Roche Pharmaceuticals China; Xie Xin, Executive Director and Senior Vice President of Sinopharm Biotech Co., Ltd.; Wu Yue, Deputy General Manager of CICC; Li Lihua, Vice President of Scientific Research Management at Biotec Group; Zhang Jing, CFO of Sidelife Medical Co., Ltd.; Liu Yiming, Managing Partner of Shanghai Office of K&L Law Offices; Wang Haijiao, Partner of GaoTec Investment Group; Wan Yong, Chairman and Chief Executive Officer of TradeGo; Sheng Zequan, Vice President of Yajie Ankang; Lin Zirong, Executive Director of Canuo Biopharmaceutical Co., Ltd.; Xiaoxiao Xiang, Chairman and CEO of Zhejiang Shimai Pharmaceutical Co., Ltd.; Jing Lan, Senior Director of Enterprise Development at Tongrui Biopharmaceutical (Shanghai) Co., Ltd.; Chen Xingrong, CEO of Fosun Kailai; Zhang Yan, Co-founder and Senior Vice President of MagnaTech; Liu Xiaolan, Co-Chair and Managing Director of Healthcare Industry Group at Investment Banking Committee; Zhou Guoying, Founder, Chairman and CEO of Yino MicroMed; Wei Jun, Co-founder and CEO of Ruijian Medicine; Jinhua Jun, CEO & Chief Technology Officer of Jun Sai Bio; Wang Hongyuan, CEO of Suzhou Huayile Health Biotechnology Co., Ltd.; Ni Dongyao, Senior Vice President of Xibiman Biotechnology, and other heavyweight guests attended the forum, presenting a feast of intellectual collision and wisdom integration for the participants.

At the meeting, the 'White Paper on the Current Situation and Development Trends of the Mitochondrial Medicine Industry in 2025' and the 'Blue Paper on the Current Situation and Development Trends of the Antibody Drug Industry in 2025' were officially released.

New Investment Summit Forum in Life Sciences (Parallel Session) —— Devices

Key speakers attending the forum included Mao Hua, Partner and Managing Director of Frost & Sullivan Greater China; Cai Jiangnan, Founder and Executive Chairman of Shanghai Chuangqi Health Development Research Institute; Cao Le, Director of the Asia-Pacific Strategic Investment Department at iHealthTech; Liu Yu, Executive Director, Executive Vice President and Chief Business Officer of Shanghai MicroPort Medical Robotics (Group) Co., Ltd.; Sun Xiaolu, Founder and Managing Partner of Binlinxing Venture Capital; Cai Linting, Vice President of the Healthcare Group at Morgan Stanley Investment Banking; Cynthia Chen, Chairman of PAMU Medical; Yang He, CEO of Weimai Medical; Zheng Hongzhe, President of the Strategy Department at Jiangsu Yuyue Medical Equipment Co., Ltd.; Xing Zhikai, Director of the Engineering Technology Center at Shanghai MicroPort Cardiovascular Medical Technology (Group) Co., Ltd.; Du Peng, Project Director at Shanghai Haohai Biotechnology Co., Ltd.; Xu Qiang, Managing Director of Sequoia China; Guo Guangxu, Chairman and CEO of Xi'an EyeMed Medical Technology Co., Ltd.; Wang Li, CEO & Chairman of Yixin Medical; Zhu Jun, General Manager of Kangfeng Biotechnology (Shanghai) Co., Ltd.; Che Haibo, Chairman of Keroche Medical Technology; Zhang Chunli, CTO of Hengyi Biotechnology; Chi Chongwei, CEO of DPM; Chen Qiqiang, Vice President of the Investment Banking Business Management Committee at CITIC Construction Investment Securities; Liu Mai, Chairman of Yongxin Medical; Ding Lin, Chief Financial Officer and Secretary of the Board of Directors of iKang Medical (Beijing) Co., Ltd.; Ye Ying, Secretary of the Board of Directors of Hanuo Medical; Ding Dingding, Head of Brand Communication and Investor Relations at Beixin Life, among others.

At the meeting, the '2025 Blue Book on the Current Situation and Trends of Medical Devices Going Global in China' and the '2025 Blue Book on the Current Situation and Future Development of Medical Aesthetic Injection Products' were officially released.

Sub-forum on the High-quality Development of Listed Companies

High-quality development is an essential requirement of Chinese-style modernization. Listed companies, as representatives of China's outstanding enterprise group, constitute an important micro foundation for high-quality development. The sub-forum on the high-quality development of listed companies, held on the afternoon of August 28th, brought together representatives from outstanding enterprises practicing and promoting high-quality development, industry leaders, investment institutions, and professional service agencies. It delved into the connotation and path of high-quality development of listed companies, explored new dynamics and trends in comprehensive high-quality development, and through in-depth exchanges and intellectual integration, sparked valuable innovative concepts and practical solutions. Together, they aim to paint a beautiful blueprint for the high-quality development of listed companies.

Key speakers at the forum included Wan Yong, Chairman of SULLIVAN TELE-TREND CLOUD TECHNOLOGY and Chief Executive Officer of TradeGo; Professor Liu Yunhong, Deputy Director of M&A Financing Committee of China Listed Companies Association and Deputy Director of International M&A and Investment Research Institute at Renmin University of China; Lin Taoxi, Secretary of the Board and BD Director of Guangdong Dongyang Pharmaceutical Co., Ltd.; Zhi Tao, Founder/Chairman of Yunji Technology; Wen Huijun, Head of RWA Business Unit at Jinzhou Holdings; Yu Zheng, Regional Head of SULLIVAN TELE-TREND CLOUD TECHNOLOGY in Shanghai and General Manager of TradeGo (Shanghai); Zheng Hongwei, Deputy Chairman of Hainan Junda New Energy Technology Co., Ltd.; Zhang Hongchen, Chief Product Officer of Different Groups and Co-founder of the BeBeBus brand; He Zhaofeng, Partner-in-Chief of Listing Services in Greater China at EY; Qi Mingyang, Chairman of the Board of Directors of Jinzhou Holdings Co., Ltd.; Zong Guisheng, Chairman of Beijing Sandi Technology Co., Ltd. and Chairman of Han Daohu Le'mo Bar; Dr. Gao Wenzhong, Executive President of China Enterprise Holdings and a council member of the All-China Federation of M&A Associations; and other heavyweight guests.

So far, the 19th Frost & Sullivan Global Growth, Innovation and Leadership Summit, as well as the 4th New Investment Conference, have come to a successful conclusion.

Once again, we would like to express our heartfelt gratitude to the supporting organizations of this conference: the China Advertising Association, the China Listed Companies Association, China Quality Supervision, and all partners at all levels for their strong support of this conference.

Dr. Wang Xin, Global Partner and Chairman of Frost & Sullivan Greater China, said: "Frost & Sullivan's mission is to convey China's growth, innovation and leadership to the world, so that the world can better understand China's value and for China to accelerate its embrace of global opportunities. The Frost & Sullivan Summit has a history of over 30 years globally and has been successfully held for 19 consecutive sessions in China without interruption. In the future, we will continue our commitment to base ourselves in Shanghai, serve China, face the world and achieve win-win cooperation. We will help enterprises realize their domestic and overseas growth strategies, empower industrial transformation and upgrading through innovation, cultivate leading Chinese entrepreneurs, and ultimately promote the high-quality development of China's economy and society!"

Frost & Sullivan will continue to work with various institutions to help enterprises accelerate their growth, assist them in achieving growth, technological innovation, and leading benchmarks within the industry. Together with all partners, we aim to build a comprehensive investment management strategy and seek certainty in the new era.

We'll meet again next year!

More exciting moments from the conference ✨